Plain-English translation of NCT07371455 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This is an early-stage clinical trial testing a new medication called . The study will give healthy volunteers different doses of this medication—starting with lower amounts and gradually increasing—to see how safe it is and how the body processes it. Researchers will carefully monitor participants to make sure the medication doesn't cause harmful side effects.
Before this medication can be tested in patients with stroke, researchers need to first understand whether it is safe in healthy people and how the body absorbs and uses it. This trial is the critical first step in that process.
You likely qualify if…
You likely don't qualify if…
Participants will visit the study site multiple times. In the first part of the study, volunteers will receive a single dose of the medication (or placebo) and be monitored to see how their bodies handle it. Then different groups will try progressively higher doses. Throughout the study, researchers will take blood samples, check vital signs, and perform heart rhythm tests (ECGs) to ensure safety. The entire study will span several weeks, with visits that may last several hours.
AI-generated summary from trial data · Jul 16, 2026 · Not medical advice
Australia
Phase
Safety & dosing
Sponsor
Longwood Pharmaceuticals (Hangzhou) Co., Ltd.
Enrollment target
~76 participants
Started
March 2026
Primary completion
July 2026
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years – 65 Years
Last updated on clinicaltrials.gov in March 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Tingting Yan
Longwood Pharmaceuticals (Hangzhou) Co., Ltd.
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.